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AMONG HEALTHY ADULT SMOKERS, 
DOES E-CIGARETTE SMOKING AS COMPARED TO 
TRADITIONAL CIGARETTE SMOKING IMPROVE 
PULMONARY FUNCTION TESTS?
STUDY #1
D’Ruiz et al. 
STUDY #2
Vardavas et al. 
STUDY #3
Barna, et al. 
OBJECTIVE
To evaluate acute changes in select 
physiological parameters associated with 
cardiovascular physiology, pulmonary 
function, and adverse events among 
groups that either completely or partially 
switched from conventional cigarettes to 
e-cigarettes or completely discontinued 
using tobacco and nicotine products 
altogether. 
To assess whether smoking an e-cigarette 
for 5 minutes effects PFTs of healthy 
smokers.
To compare DIS in healthy subjects with a 
history of conventional cigarette smoking, 
after using an e-cigarette and after 
returning to smoking conventional 
cigarettes for 1 week. 
SAMPLE SIZE 105 30 24
STUDY 
RESULTS
The PFT results showed small, but non-
statistically significant improvements in 
FEV1 and FVC is most user groups.
Using an e-cigarette for as little as 5 
minutes resulted in physiologic responses 
based on impulse oscillometry.
There were statistically significant 
decreases in FVC and FEV1 after 1 week 
of traditional cigarette use. No significant 
differences in PEF and FEV1/FVC were 
found between cigarette and e-cigarette 
use. 
CONCLUSION
The use of e-cigarettes for five days under 
the various study conditions did not lead 
to negative respiratory health outcomes. 
Further long-term studies are needed to 
evaluate the risks of e-cigarette use. 
Although changes to pulmonary flow 
resistance noted during the study were too 
small to induce any clinically relevant 
symptoms in study participants, 
researchers claim that the general public is 
at a higher risk of becoming symptomatic 
with increased regular use.
The harm associated with e-cigarette use 
is less significant than that of 
conventional cigarettes. They 
recommended e-cigarettes be used as a 
tool to help patients who are heavy 
smokers quit smoking.
LIMITATIONS
• Short-term five-day trial is difficult to 
translate into long-term patient 
recommendations 
• Only one type of e-cigarette product 
was investigated 
• Study failed to report spirometry data 
other than baseline measurements.
• Without explicit data from this study, 
we were unable to assess their findings
• Poor control of smoking frequency, 
methods, and nicotine intake prior to 
and during the experiment
• Sample size small 
• All participants were male
• Study groups were not randomized or 
blinded
INTRODUCTION
Electronic cigarettes (e-cigarettes) first appeared on 
the U.S. market in 20071, but to date, little is known about their 
safety. Concern about long term adverse effects on overall 
health continues to increase as we explore the potential of e-
cigarettes to aid in smoking cessation practices. E-cigarettes 
have gained popularity and support through this idea that by 
using them to help patients quit smoking, the benefits of 
ultimately abstaining from tobacco use will outweigh the harms 
associated with e-cigarette use1. 
While the idea of reducing tobacco usage by any 
means possible remains the goal for most providers, without 
clear-cut recommendations from the Food and Drug 
Administration (FDA) and Centers for Disease Control (CDC) 
and supportive long term research and data analysis, providers 
are being forced to decide between the lesser of two evils. 
CONCLUSION
The results of the 3 studies 
revealed a lack of statistically 
significant changes in pulmonary 
function (FEV1 and FVC) with the use 
of e-cigarettes vs. conventional 
cigarettes. 
Further well-designed long-term 
RCT’s are needed in order to elicit 
more conclusive evidence on the safety 
of e-cigarettes before formal 
recommendations can be made to 












FVC 16 5 3 24
FEV1 2 22 0 24
Figure 3. Suspected E-cigarette Induced Pneumonitis (CXR, HRCT).5Figure 1. Study #1 Results.2 Table 1. Study #3 Results.4
Figure 2. E-Cigarette Diagram.1
